Relay Therapeutics Q4 Earnings Assessment
Benzinga Insights 8 months ago
Earnings
Relay Therapeutics (NASDAQ:RLAY) announced its Q4 earnings on Thursday, February 26, 2026 at 04:05 PM.
Here's a breakdown of the earnings report.
Earnings
Relay Therapeutics beat estimated earnings by 17.95%, reporting an EPS of $-0.32 versus an estimate of $-0.39.
Revenue was up $7.00 million from the same period last year.
Historical Earnings Summary
The company missed on EPS by $0.02 in the previous quarter, leading to a 7.35% drop share price change the next day.
Here's a look at Relay Therapeutics's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.41 | -0.48 | -0.51 | -0.55 |
| EPS Actual | -0.43 | -0.41 | -0.46 | -0.45 |
| Revenue Estimate | 332K | 245K | 11K | 5.53M |
| Revenue Actual | 0 | 677K | 7.68M | 0 |
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Relay Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.